This inventor holds 1 USPTO granted patent. Top assignees: Institute Fisioterapici Ospitalieri, Universita' Delgi Studi “Tor Vergate”. Active years: 2013.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2013
Title: Sabina Pucci: Innovator in Tumor Diagnosis
Introduction
Sabina Pucci is a notable inventor based in Rome, Italy. She has made significant contributions to the field of medical diagnostics, particularly in the area of tumor aggressiveness prediction. Her innovative work has the potential to enhance the accuracy of cancer diagnoses and treatment plans.
Latest Patents
Sabina Pucci holds a patent for "Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits." This invention involves anti-clusterin oligoclonal antibodies that can selectively recognize and bind to specific antigenic epitopes of clusterin isoforms. These antibodies are designed for use in tumor diagnosis and predicting the malignancy grade of tumors, along with associated diagnostic methods and kits.
Career Highlights
Throughout her career, Sabina has worked with esteemed institutions such as Università degli Studi “Tor Vergata” and the Institute Fisioterapici Ospitalieri. Her research and development efforts have been pivotal in advancing diagnostic methodologies in oncology.
Collaborations
Some of her notable coworkers include Luigi Giusto Spagnoli and Flavia Pichiorri. Their collaborative efforts have contributed to the success of her innovative projects.
Conclusion
Sabina Pucci's work exemplifies the intersection of innovation and healthcare, particularly in improving cancer diagnosis and treatment. Her contributions are invaluable in the ongoing fight against cancer, showcasing the importance of research and development in medical science.